XML 54 R28.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Employee Benefit Plans | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Employee Benefit Plans | Employee Benefit Plans Stock Purchase Plan FIS employees participate in an Employee Stock Purchase Plan ("ESPP"). Eligible employees may voluntarily purchase, at current market prices, shares of FIS' common stock through payroll deductions. Pursuant to the ESPP, employees may contribute an amount between 3% and 15% of their base salary and certain commissions. Shares purchased are allocated to employees based upon their contributions. The Company contributes a matching amount as specified in the ESPP of 20% of the employee's contribution. The Company recorded expense in continuing operations of $10 million, $11 million, and $17 million, respectively, for the years ended December 31, 2024, 2023 and 2022, relating to the participation of FIS employees in the ESPP. The Company recorded expense in discontinued operations of less than $1 million, $1 million and $2 million, respectively, for the years ended December 31, 2024, 2023 and 2022, relating to the participation of Worldpay-related employees in the ESPP. 401(k) Profit Sharing Plan and Non-U.S. Defined Contribution Plans The Company's U.S. employees are covered by a qualified 401(k) plan. Eligible employees may contribute up to 40% of their eligible compensation, up to the annual amount allowed pursuant to the Internal Revenue Code. The Company generally matches 50% of each dollar of employee contribution up to 6% of the employee's total eligible compensation. The Company's non-U.S. employees are also covered by various defined contribution plans. The Company recorded expense in continuing operations of $107 million, $106 million and $109 million, respectively, for the years ended December 31, 2024, 2023 and 2022, relating to the participation of FIS employees in the 401(k) plan and the Company's contributions to non-U.S. defined contribution plans. The Company recorded expense in discontinued operations of $3 million, $29 million and $25 million, respectively, for the years ended December 31, 2024, 2023 and 2022, relating to the participation of Worldpay-related employees in the 401(k) plan and the Company’s contributions to non-U.S. defined contribution plans. Stock Compensation Plans The Company grants to certain employees equity awards pursuant to shares authorized under the FIS 2022 Omnibus Incentive Plan established in 2022 ("FIS Plan"). The number of shares available for future grants under the FIS Plan is 24 million as of December 31, 2024. Stock Options The Company grants stock options which typically vest annually over three years. All stock options are non-qualified stock options, the stock options granted by the Company expire on the seventh anniversary of the grant date, and the stock options converted through the Company's 2019 acquisition of Worldpay expire on the tenth anniversary of the grant date. The following table summarizes stock option activity for the year ended December 31, 2024, which includes both continuing and discontinued operations (in millions except for per share amounts):
| Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value
Balance, December 31, 2023 | 8 |  |  | $ | 100.19 |  |  | 3.3 |  | $ | — |
Granted | — |  |  | — |  |  |  |  |
Exercised | — |  |  | 65.23 |  |  |  |  | $ | 1 |
Cancelled | (1) |  |  | 86.42 |  |  |  |  |
Balance, December 31, 2024 | 7 |  |  | $ | 103.85 |  |  | 2.9 |  | $ | 6 |
Options exercisable at December 31, 2024 | 5 |  |  | $ | 110.51 |  |  | 2.3 |  | $ | 3 |
The intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022, was $1 million, $8 million and $20 million, respectively. The intrinsic value of the outstanding options and options exercisable is based on a closing stock price as of December 31, 2024, of $80.77. The Company issues authorized but unissued shares or shares from treasury stock to settle stock options exercised. The number of options granted for the years ended December 31, 2023 and 2022, was 2 million and 1 million, respectively. The weighted average exercise price was $78.42 and $95.06 for the years ended December 31, 2023 and 2022, respectively. The Company did not grant any stock options during the year ended December 31, 2024. The weighted average fair value of options granted during the years ended December 31, 2023 and 2022, was $12.91 and $20.89, respectively, using the Black-Scholes option pricing model with the assumptions below:
|  | 2023 |  | 2022
Risk free interest rate |  | 4.2 | % |  | 1.7 | %
Volatility |  | 37.6 | % |  | 30.5 | %
Dividend yield |  | 3.3 | % |  | 2.0 | %
Weighted average expected life (years) |  | 4.1 |  | 4.1
The Company estimates future forfeitures at the time of grant and revises those estimates in subsequent periods if actual forfeitures differ significantly from those estimates. The Company bases the risk-free interest rate that is used in the Black-Scholes model on U.S. Treasury securities issued with maturities similar to the expected term of the options. The expected stock volatility factor is determined using historical daily price of the common stock and the impact of any expected trends. The dividend yield assumption is based on the current dividend yield at the grant date or management's forecasted expectations. The expected life assumption is determined by calculating the average term from the Company's historical stock option activity and considering the impact of future trends. Restricted Stock Units and Performance Stock Units The Company issues restricted stock units, which typically vest annually over three years. The grant date fair value of the restricted stock units is based on the fair market value of our common stock on the grant date. The number of restricted stock units granted during the years ended December 31, 2024, 2023 and 2022, was 3 million, 3 million and 1 million, respectively. The weighted average grant date fair value of these awards granted during the years ended December 31, 2024, 2023 and 2022, was $70.65, $61.34 and $92.07, respectively. The total fair value of restricted stock units that vested was $93 million, $40 million and $261 million in 2024, 2023 and 2022, respectively. The Company grants performance-based stock units that typically cliff vest on the third anniversary date of the grant. The ultimate number of units to be earned depends on the achievement of performance conditions. Some performance-based stock units also include market conditions. The performance conditions are typically based on a measure of the Company’s Adjusted revenue growth and Adjusted Earnings Per Share. In 2024, following the completion of the Worldpay Sale, the Company modified the performance criteria for the 2024 performance year under the outstanding 2022 performance stock units to match the performance criteria for the 2024 performance year included in the performance stock units granted in 2024, since the prior criteria were established when FIS owned Worldpay and were no longer appropriate following the sale. The modification did not result in significant incremental compensation costs. The market conditions are based on the Company’s total shareholder return ranked against that of other companies that are included in the Standard & Poor’s 500 Index. The fair value of each performance-based stock unit with only performance conditions is based on the fair value of our common stock on the grant date. The fair value of each performance-based stock unit with a market condition is estimated on the date of grant using a Monte Carlo simulation model with the following weighted-average assumptions:
| 2024 |  | 2023 |  | 2022
Risk free interest rate | 4.3 | % |  | 4.6 | % |  | 1.6 | %
Volatility | 38.6 | % |  | 37.2 | % |  | 34.2 | %
Dividend yield | 2.1 | % |  | 3.3 | % |  | 2.0 | %
The number of performance-based stock units granted during the years ended December 31, 2024, 2023 and 2022, was less than 1 million, 1 million and 2 million, respectively. The weighted average grant date fair value of these awards granted during the years ended December 31, 2024, 2023 and 2022, was $69.75, $65.43 and $99.27, respectively. The total fair value of the performance-based stock units that vested was $17 million, $10 million and $35 million in 2024, 2023 and 2022, respectively. The following table summarizes the restricted stock units and performance stock units activity for the year ended December 31, 2024, which includes both continuing and discontinued operations (in millions except for per share amounts):
| Restricted Stock Units |  | Performance Stock Units
| (In millions) |  |  |  | (In millions) |  |
| Shares |  | Weighted Average Fair Value |  | Shares |  | Weighted Average Fair Value
Balance December 31, 2023 | 4 |  |  | $ | 70.24 |  |  | 2 |  |  | $ | 96.33 |
Granted | 3 |  |  | $ | 70.65 |  |  | 1 |  |  | $ | 69.75 |
Vested | (2) |  |  | $ | 73.34 |  |  | — |  |  | $ | 141.52 |
Forfeited | (1) |  |  | $ | 70.26 |  |  | (1) |  |  | $ | 106.10 |
Balance December 31, 2024 | 4 |  |  | $ | 69.52 |  |  | 2 |  |  | $ | 82.44 |
Stock Compensation Cost The Company recorded total stock compensation expense in continuing operations of $186 million, $120 million and $189 million for the years ended December 31, 2024, 2023 and 2022, respectively, included in Selling, general, and administrative expenses in the consolidated statements of earnings (loss). The Company recorded total stock compensation expense in discontinued operations of $3 million, $34 million and $26 million for the years ended December 31, 2024, 2023 and 2022, respectively. Stock compensation expense related to grants with performance conditions is recorded based on management's expected level of achievement of the financial performance measures during the performance period and is adjusted as appropriate throughout the performance period based on the shares expected to be earned. As of December 31, 2024, the total unrecognized compensation cost related to non-vested stock awards was $222 million. As of December 31, 2023, the total unrecognized compensation cost, including continuing and discontinued operations, was $219 million. The total unrecognized compensation cost as of December 31, 2024 and 2023, includes $222 million and $166 million, respectively, related to continuing operations, which is expected to be recognized in pre-tax income over a weighted average period of 1.5 years and 1.4 years, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration